Exploratory Study to Evaluate the Safety and Efficacy of CD10367 in Subjects With Psoriasis
Latest Information Update: 25 Sep 2024
At a glance
- Drugs CD 10367 (Primary) ; Betamethasone valerate
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Galderma
- 04 Apr 2017 Status changed from recruiting to completed.
- 24 Jan 2017 New trial record